| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2015 | WO2015011036A1 Compositions and methods using p-anisaldehyde |
| 01/29/2015 | WO2015011008A1 7-azaindole derivatives as parp inhibitors |
| 01/29/2015 | WO2015010927A1 Pharmaceutical composition for oral insulin administration comprising a tablet core and an anionic copolymer coating |
| 01/29/2015 | WO2015010782A1 Cancer therapy with a parvovirus combined with a bcl-2 inhibitor |
| 01/29/2015 | WO2015010666A2 Phenol derivative and use thereof |
| 01/29/2015 | WO2015010655A1 Triadic fused cyclic carboxylic acids derivatives, preparation method therefor and pharmaceutical use thereof |
| 01/29/2015 | WO2015010641A1 Substituted quinazolin-4-one derivatives |
| 01/29/2015 | WO2015010626A1 Therapeutically active compounds and use thereof |
| 01/29/2015 | WO2015010594A1 Indoline compound, preparation method therefor, pharmaceutical composition, and application thereof |
| 01/29/2015 | WO2015010449A1 Method for use of vitamin b composition to promote motility of gastrointestinal system |
| 01/29/2015 | WO2015010442A1 Biomarkers for premature birth |
| 01/29/2015 | WO2015010439A1 Pharmaceutical, water-soluble and antifungal macromolecular compound |
| 01/29/2015 | WO2015010297A1 Therapeutically active compounds and their methods of use |
| 01/29/2015 | WO2015010293A1 Anticancer pharmaceutical composition, preparation method for same, and use thereof |
| 01/29/2015 | WO2015010217A1 Dimiracetam in the treatment of depression |
| 01/29/2015 | WO2015010194A1 Composition for the management of nausea and vomiting |
| 01/29/2015 | US20150032088 Sustained drug delivery from solid state compositions with nanochannel membranes |
| 01/29/2015 | US20150032045 Photolabile compounds |
| 01/29/2015 | US20150031897 Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases |
| 01/29/2015 | US20150031893 An h3 receptor antagonist for use in the treatment of alzheimer's disease |
| 01/29/2015 | US20150031882 Methods for treating cancer using pi3k inhibitor and mek inhibitor |
| 01/29/2015 | US20150031881 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 01/29/2015 | US20150031872 Method for screening anticancer drugs, and anticancer drug that induces cell death and uses substance that increases granzyme m activity as active ingredient |
| 01/29/2015 | US20150031861 Chemical Modification of Antibodies |
| 01/29/2015 | US20150031832 Carrier nanoparticles and related compositions, methods and systems |
| 01/29/2015 | US20150031776 Method of preventing, treating and diagnosing disorders of protein aggregation |
| 01/29/2015 | US20150031775 Composition and method for affecting male and female hormone levels |
| 01/29/2015 | US20150031774 Rasagiline orally disintegrating compositions |
| 01/29/2015 | US20150031773 Pharmaceutical Composition for Preventing or Treating Muscle Wasting-Related Disease Comprising Diaminodiphenylsulfone or Pharmaceutically Acceptable Salt Thereof |
| 01/29/2015 | US20150031771 Pharmaceutical composition for preventing or treating hepatic fibrosis and cirrhosis containing ramalin |
| 01/29/2015 | US20150031768 C-halogen bond formation |
| 01/29/2015 | US20150031767 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| 01/29/2015 | US20150031765 Treatment of cognitive impairment |
| 01/29/2015 | US20150031761 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 01/29/2015 | US20150031760 Pharmaceutical composition for preventing or treating nervous system disorders comprising sulfuretin or pharmaceutically acceptable salt thereof |
| 01/29/2015 | US20150031758 Transition metal complexes of a bis[thiohydrazide amide] compound |
| 01/29/2015 | US20150031752 Coated lipid complexes and their use |
| 01/29/2015 | US20150031751 Compositions and methods for treatment of ovarian cancer |
| 01/29/2015 | US20150031743 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 01/29/2015 | US20150031741 Compositions and methods for improving lactation |
| 01/29/2015 | US20150031739 Panobinostat for use in the treatment of hiv-1 |
| 01/29/2015 | US20150031737 Stabilized controlled-release pharmaceutical composition comprising gliclazide |
| 01/29/2015 | US20150031736 Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| 01/29/2015 | US20150031734 Pharmaceutical composition containing mirabegron |
| 01/29/2015 | US20150031732 Febuxostat solid dispersion |
| 01/29/2015 | US20150031731 Polymorph of a pharmaceutical |
| 01/29/2015 | US20150031728 Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures |
| 01/29/2015 | US20150031725 Compositions and methods for treating cancer |
| 01/29/2015 | US20150031724 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/29/2015 | US20150031723 Quinoline Compounds Which Are Anti-Angiogenic Integrin Alpha5 Beta1 Inhibitors for Use in the Treatment of Fibrosis or Fibrosis-Related Diseases |
| 01/29/2015 | US20150031722 Modulators of atp-binding cassette transporters |
| 01/29/2015 | US20150031719 Topical Therapy for the Treatment of Migraines, Muscle Sprains, Muscle Spasms, Spasticity and Related Conditions |
| 01/29/2015 | US20150031718 Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent |
| 01/29/2015 | US20150031712 Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same |
| 01/29/2015 | US20150031710 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 01/29/2015 | US20150031708 Modulators of cftr |
| 01/29/2015 | US20150031707 Method for preparing nano particles |
| 01/29/2015 | US20150031706 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 01/29/2015 | US20150031705 Ophthalmic formulations including selective alpha 1 antagonists |
| 01/29/2015 | US20150031704 Methods and compositions for treating peripheral vascular disease |
| 01/29/2015 | US20150031703 Novel fgfr3 fusion |
| 01/29/2015 | US20150031701 Compositions and methods for preventing and treating mucositis and weight loss |
| 01/29/2015 | US20150031700 Methods of Treating Cutaneous Flushing Using Selective Alpha-2-adrenergic Receptor Agonists |
| 01/29/2015 | US20150031699 Treatment of myelodysplastic syndrome |
| 01/29/2015 | US20150031697 Method for preventing ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas |
| 01/29/2015 | US20150031687 Novel 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection |
| 01/29/2015 | US20150031683 Rho kinase inhibitors for use in treating amyotrophic lateral sclerosis |
| 01/29/2015 | US20150031682 Anti-malarial agents |
| 01/29/2015 | US20150031681 Novel 1-substituted indazole derivative |
| 01/29/2015 | US20150031680 Selective Estrogen Receptor Modulators With Short Half-Lives and Uses Thereof |
| 01/29/2015 | US20150031677 Trioxane thioacetal monomers and dimers and methods of use thereof |
| 01/29/2015 | US20150031676 Substituted benzothienyl-pyrrolotriazines and uses thereof |
| 01/29/2015 | US20150031673 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/2015 | US20150031671 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 01/29/2015 | US20150031670 Cyclic amides as metap-2 inhibitors |
| 01/29/2015 | US20150031669 Anticancer benzopyrazines via the inhibition of fgfr kinases |
| 01/29/2015 | US20150031666 1,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitors |
| 01/29/2015 | US20150031665 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| 01/29/2015 | US20150031662 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 01/29/2015 | US20150031660 1,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitors |
| 01/29/2015 | US20150031659 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
| 01/29/2015 | US20150031658 Ethoxyphenyl thienyl compounds and methods for the treatment of bacterial infections |
| 01/29/2015 | US20150031656 Combination therapy for treating androgen deficiency |
| 01/29/2015 | US20150031655 Combination of liver x receptor modulator and estrogen receptor modulator for the treatment of age-related diseases |
| 01/29/2015 | US20150031654 Natural combination hormone replacement formulations and therapies |
| 01/29/2015 | US20150031653 Method of treating, delaying and/or preventing alzheimer's disease |
| 01/29/2015 | US20150031652 Poly (adp-ribose) polymerase (parp) inhibitors |
| 01/29/2015 | US20150031649 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| 01/29/2015 | US20150031648 Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/2015 | US20150031647 Taste masked dispersible tablets |
| 01/29/2015 | US20150031646 Carrier enhancing absorption of medication |
| 01/29/2015 | US20150031645 Methods of using human milk oligosaccharides for improving airway respiratory health |
| 01/29/2015 | US20150031643 Combination treatment of acute myeloid leukemia and myelodysplastic syndrome ii |
| 01/29/2015 | US20150031642 Combination treatment of acute myeloid leukemia and myelodysplastic syndrome i |
| 01/29/2015 | US20150031641 Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia |
| 01/29/2015 | US20150031640 Antibacterial agents: combination of a rifamycin and a switch region inhibitor |
| 01/29/2015 | US20150031639 New c-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. therapeutic applications of the synthesized agent(s) and of genista tenera ethyl acetate extracts containing some of those agents |
| 01/29/2015 | US20150031638 Low anticoagulant heparins |
| 01/29/2015 | US20150031636 Ibat inhibitors for the treatment of liver diseases |
| 01/29/2015 | US20150031635 Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids |